Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2010
12/02/2010CA2761904A1 Treatment of tissue adhesion
12/02/2010CA2761744A1 Methods for administration and formulations for the treatment of regional adipose tissue
12/02/2010CA2761639A1 Aryl substituted carboxamide derivatives as calcium or sodium channel blockers
12/02/2010CA2761597A1 Anti-shock agent comprising diaminotrifluoromethylpyridine derivative
12/02/2010CA2761445A1 Bicyclic pyrimidine pi3k inhibitor compounds selective for p110 delta, and methods of use
12/02/2010CA2761250A1 Pharmaceutical composition comprising prostaglandin derivatives for use in modulating claudin mediated functions and in the treatment of dermatological disorders
12/02/2010CA2761157A1 Ketal esters of anhydropentitols and uses thereof
12/02/2010CA2760284A1 Novel glucocorticoid receptor agonists
12/02/2010CA2759182A1 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
12/02/2010CA2757702A1 Resolution of (±)-methyl phenyl[4-[4-[[[4'-(trifluoromethyl)-2-biphenylyl]carbonyl]amino]phenyl]-1-piperidinyl]acetate
12/01/2010EP2256500A2 Use of inhibitors of the enzyme TKTL1.
12/01/2010EP2256498A1 Methods of diagnosing or treating irritable bowel syndrome and other disorders
12/01/2010EP2256210A1 Wickerol and process for production thereof
12/01/2010EP2256203A1 IL-23 and its receptor; related reagents and methods
12/01/2010EP2256201A2 Modulation of eIF4E expression
12/01/2010EP2256200A2 Modulation of eIF4E expression
12/01/2010EP2256191A1 Cyclic single-stranded nucleic acid complex and method for producing the same
12/01/2010EP2256138A1 Novel acylated 1,6-anhhydro decasaccharide and its use as antithrombotic agent
12/01/2010EP2256136A1 Novel acylated decasaccharides and their use as antithrombotic agents
12/01/2010EP2256124A1 Phospho-indoles as HIV inhibitors
12/01/2010EP2256119A1 Vasopressin V1a antagonists
12/01/2010EP2256118A1 Condensed imidazolo derivatives for the inhibition of aromatase
12/01/2010EP2256117A1 Quiniclidine derivatives of (hetero) arylcycloheptanecarboxylic acid as muscarinic receptor antagonists
12/01/2010EP2256116A2 Aryl sulfonamides
12/01/2010EP2256115A1 Heteromonocyclic compound and use thereof
12/01/2010EP2256114A1 Amide derivative and pharmaceutical composition containing the same
12/01/2010EP2256113A1 Inhibitors of serine proteases
12/01/2010EP2256112A1 Anthranilamides, process for the production thereof and pest controllers containing the same
12/01/2010EP2256109A1 Apoptosis inhibitor
12/01/2010EP2256108A1 Substituted triazine kinase inhibitors
12/01/2010EP2256107A1 Amino-5-[4-(difluoromethoxy)phenyl]-5-phenylimidazolone compounds as inhibitors of the beta-secretase (BACE)
12/01/2010EP2256106A1 3,4-disubstituted 1H-pyrazole compounds and their use as cyclin dependent kinases (CDK) and glycogen synthase kinase-3 (GSK-3) modulators
12/01/2010EP2256105A1 Novel tetrahydroisoquinoline derivative
12/01/2010EP2255848A2 Pharmaceutical combinations of a nicotine receptor modulator and a cognitive enhancer
12/01/2010EP2255830A1 Concomitant drug
12/01/2010EP2255829A2 Pharmaceutical composition for treatment of diseases associated with decrease in bone mass comprising EP4 agonist as active ingredient
12/01/2010EP2255821A1 Micro/nanoparticle obtained from lipid-containing marine organisms for use in pharmaceutics and cosmetics
12/01/2010EP2255818A1 Oral or enteral composition useful for recovery of physical functions
12/01/2010EP2255817A1 Use of an acylated octasaccharide as antithrombotic agent
12/01/2010EP2255816A1 Use of compounds extracted from momordica charantia l. in the manufacture of medicaments for prevention and treatment of diabetes and obesity
12/01/2010EP2255815A2 Nutritional Composition
12/01/2010EP2255814A1 Agent for increasing the quantity of hyaluronic acid
12/01/2010EP2255813A1 Derivatives of ursodeoxycholic acid for the treatment of diarrhoea
12/01/2010EP2255812A1 Methods and compositions for reducing neurodegeneration in amyotrophic lateral sclerosis
12/01/2010EP2255811A1 Mequitazine for treating or preventing pathologies involving histamine H4 receptors
12/01/2010EP2255810A1 Pharmaceutical forms comprising vardenafil and having a controlled bioavailability
12/01/2010EP2255808A2 Opioids for the treatment of the restlessness of the lower limbs
12/01/2010EP2255807A1 Method of treating sleep disorders using the combination of eplivanserin and zolpidem
12/01/2010EP2255806A2 Fentanyl composition for nasal administration
12/01/2010EP2255805A1 Deferasirox for the treatment of hereditary hemochromatosis
12/01/2010EP2255804A1 A pharmaceutical composition and the application thereof in the preparation of medicine for the treatment of cerebrovascular diseases
12/01/2010EP2255803A1 Oral galenic formulation including ketorolac and b-complex vitamins, in which vitamin b6 is in an outer layer separated from the rest of the active principles
12/01/2010EP2255802A1 Adhesive skin patch and packaged product
12/01/2010EP2255801A1 Pharmaceutically active isoindoline derivatives
12/01/2010EP2255800A1 Arsenic trioxide for use in the treatment of leukaemia
12/01/2010EP2255799A1 Agent for combating the side effects of cancer chemotherapy
12/01/2010EP2255798A2 Sphingosine-1-phosphate receptor agonists for use in the treatment of optic neuritis
12/01/2010EP2255796A2 Pharmaceutical preparation
12/01/2010EP2255791A1 Extended release pharmaceutical composition comprising metoprolol succinate
12/01/2010EP2255790A1 Liposome composition comprising naproxen, and a method of obtaining same
12/01/2010EP2255787A1 Synthetic glycolipid-containing liposomes
12/01/2010EP2255786A1 Self-microemulsifying mitotane composition
12/01/2010EP2255785A2 Stable emulsion composition
12/01/2010EP2255784A1 Composition for easing human childbirth
12/01/2010EP2255783A2 Azelaic acid gel, and a method of obtaining same
12/01/2010EP2255745A1 System for concurrent tooth repositioning and substance delivery
12/01/2010EP2255738A2 Spine distraction implant
12/01/2010EP2255737A2 Spine distraction implant
12/01/2010EP2255736A2 Spine distraction implant
12/01/2010EP2255735A2 Spine distraction implant
12/01/2010EP2255668A2 Production and Use of a Polar Lipid-Rich Fraction Containing Omega-3 and/or Omega-6 Highly Unsaturated Fatty Acids from Microbes, Genetically Modified Plant Seeds and Marine Organisms
12/01/2010EP2255667A1 Pasteurisation process for microbial cells and microbial oil
12/01/2010EP2255666A1 Pasteurisation process for microbial cells and microbial oil
12/01/2010EP2255661A2 Enteric formulations of proanthocyanidin polymer antidiarrheal compositions
12/01/2010EP2255624A1 Inhibitor for growth of bacteria of genus legionella, bath agent and cleaning agent
12/01/2010EP2254899A1 Blocking the metastasis of cancer cells and the uses of new compounds thereof
12/01/2010EP2254893A1 Novel 7-substituted derivatives of 3-carboxy-oxadiazino-quinolones, preparation thereof and use thereof as anti-bacterial agents
12/01/2010EP2254892A1 Bicyclic nitroimidazoles covalently linked to substituted phenyl oxazolidinones
12/01/2010EP2254890A1 Process for the diastereoisomeric resolution of 5-methyltetrahydrofolic acid
12/01/2010EP2254889A1 Protein kinase inhibitors and use thereof
12/01/2010EP2254888A1 Novel aminopyridine derivatives having aurora a selective inhibitory action
12/01/2010EP2254887A1 Oxazolidinone derivatives
12/01/2010EP2254885A1 (pyrazolyl carbonyl)imidazolidinone derivatives for the treatment of retroviral diseases
12/01/2010EP2254884A2 3-alkyl-piperazine derivatives and uses thereof
12/01/2010EP2254883A1 Substituted indole derivatives
12/01/2010EP2254882A2 Intermediates and a process employing the intermediates for the preparation of (3-trifluoromethylsulfonyl)-n-[4-methyl-3- (4-pyridin-3-yl-pyrimidin-2ylamino)-phenyl]-benzamide
12/01/2010EP2254881A1 Chlorothiophene-amides as inhibitors of coagulation factors xa and thrombin
12/01/2010EP2254880A2 Macrocyclic prodrug compounds useful as therapeutics
12/01/2010EP2254878A1 Aldh-2 inhibitors in the treatment of addiction
12/01/2010EP2254876A1 Compound (r) -n*6*-ethyl-6, 7-dihydro-5h-indeno (5, 6- d) thiazole-2, 6-diamine and the use as antipsychotics
12/01/2010EP2254870A2 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, cx3cr1
12/01/2010EP2254869A2 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, cx3cr1
12/01/2010EP2254868A1 Novel 4-benzhydryl-tetrahydro-pyridine derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
12/01/2010EP2254867A1 Substituted sulfonamide derivatives
12/01/2010EP2254866A1 Novel 4-benzhydryloxy-tetraalkyl-piperidine derivatives and their use as monoamine neurotransmitter re-uptatke inhibitors
12/01/2010EP2254865A1 Indole compounds and methods of use thereof
12/01/2010EP2254864A1 Substituted 4-aminocyclohexane derivatives for the treatment of pain
12/01/2010EP2254862A2 Azetidine-derived compounds, preparation method therefor and therapeutic use of same
12/01/2010EP2254861A1 The 1,3-disubstituted ureas, method of re aration and utilisation thereof
12/01/2010EP2254860A1 Derivatives of 4-(2-amino-1-hydroxyethyl) phenol as agonists of the b2 adrenergic receptor
1 ... 1979 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 ... 7860